Lataa...

Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

BACKGROUND: The exhaustive registry of COVID-19 cases in patients with IBD is a unique opportunity to learn how to deal with this infection, especially in reference to the management of immunosuppressive treatment, isolation measures or if the disease is more severe in IBD patients due to immunosupp...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Julkaisussa:	J Crohns Colitis
Päätekijät:	Zabana Abdo, Y, Marín-Jiménez, I, Rodríguez-Lago, I, Ramírez Esteso, F, Meijilde, S, Ramos, L, Gomollón, F, Muñoz, F, Suris, G, Ortiz de Zárate, J, Huguet, J M, Llaó, J, García-Sepulcre, M, Sierra, M, Durà, M, Estrecha, S, Fuentes Coronel, A, Hinojosa, E, Olivan, L, Iglesias, E, Gutiérrez, A, Varela, P, Rull, N, Gilabert, P, Hernández-Camba, A, Brotons, A, Ginard, D, Sesé, E, Carpio, D, Aceituno, M, Cabriada, J L, González-Lama, Y, Jiménez, L, Chaparro, M, López-San Román, A, Alba, C, Plaza-Santos, R, Piqueras, M, Domènech, E, Esteve, M
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Oxford University Press 2021
Aiheet:	Poster Presentations
Linkit:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8194955/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab076.729
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

Samankaltaisia teoksia